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Abstract 
Annexin-1 is a calcium dependent phospholipid binding and phospholipase A2 (PLAx) inhibitory protein. A ‘substrate depletion’ model has been 
proposed for the mechanism of PI_& inhibition by annexin- in studies with 14 to 18 kDa PLA,s. Herein, we have studied the inhibition mechanism 
using 100 kDa cytosolic PLA, from porcine spleen. The ~ibition has been measured at various substrate and calcium ion con~ntrations. The pattern 
of PLA, inhibition by annexin- was consistent with a ‘specific interaction’ mechanism rather than the ‘substrate depletion’ model. Apparent 
contradiction with previous studies can be explained by the calcium-dependent binding of annexin-1 to the substrate. 
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1. r&roduction 
Annexins are widely distributed calcium- and phos- 
pholipid-binding proteins that have been implicated in 
various physiological roles including phospholipase A, 
(PLAJ inhibition, membrane fusion, anti-~fla~ation, 
anti-coagulation, differentiation, cell adhesion, exocyto- 
sis and interaction with cytoskeletal proteins (see [l-3] 
for references). However, a well-defined biological func- 
tion has not been determined for any of the annexins. 
binding of annexin- to the substrate is calcim ion- 
dependent [lo] the inhibition of PLA, by annexin- may 
also be calcium ion-dependent. The 14 kDa PLA, which 
has been extensively studied requires millimolar Ca” 
concentration for activation. Therefore, it has not been 
possible to investigate in~bition by annexin-1 under a 
wide range of calcium ion concentrations using the 14 
kDa PLA,. 
Annexin- has been shown to be a major substrate for 
epidermal growth factor receptor kinase [4] and impli- 
cated in the regulation of signal transduction pathways 
of various mitogenic signals which are thought to be 
involved with PLA, inhibition in vivo [5-71. 
Recently, intracellular forms of PLA,s with apparent 
sixes of 80 to 100 kDa have been found in a variety of 
mammalian cells [ll-151. In contrast to the 14 kDa 
PLA,, these enzymes are activated under micromolar 
Ca” concentrations and selective to arachidonate-con- 
taming phospholipid. 
The mechanism of PLAz inhibition by annexin-1 has 
not been fully understood. Detailed in vitro studies on 
the effect of annexins on a 14 kDa PLA, from porcine 
pancreas have indicated that PLAz inhibition by an- 
nexin-I is due to depletion of the substrate [8,9]. Since the 
In this contribution, the PLA, inhibition by annexin-1 
was studied using a 100 kDa cytosolic PLA, from por- 
cine spleen to investigate whether in~bition by annexin- 
is due to ‘substrate depletion’ or to ‘specific interaction’ 
with PLA,. 
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**Present address: Renal Unit, Jackson 8, Massachusetts General 
Hospital, Fruit Street, Boston, MA 02114, USA. 
2.1. Materials 
***Present address: Dept. of Biology, Sung Kyun Kwan University, 
300 Chunchun-dong, Jangan-ku, Suwon, Kyungki-do 440-746, Korea. 
Abbreviations: PLA,, phospholipase A,; 2-AA-PC, L-S-phosphati- 
dylcholine, Zarachidonoyl; 2-AA-PE, L-3-phosphatidylethanolamine, 
2-arachidonoyl. 
l-Stearoyl-2-[l-‘4~arachidonoyl-sn-glycero-3-p hosphocholine (2- 
AA-PC) (56.0 mCi/mmol) and I-acyl-2-[l-“‘Clarachidonoyl-rn-glvcero- 
3-phosphoe thanolam&(2-AA-P@ (57.0 mCi/mmol) were puiihased 
from Amersham (Buckinghamshire, UK) and used as substrates. Unla- 
baled 2-AA-PC, purchased from Sigma (St. Louis, MO, USA) was also 
used. ~tillation fluid (Aquasol-2) was obtained from NEN Research 
Products (Boston, MA, USA) and Fura- was from Molecular Probe 
(Eugene, OR, USA). All other reagents were analytical reagent grade 
or better. 
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2.2. Purijication of Annexin-Z and PLAz 
Annexin- cDNA was cloned and expressed in E. coli. The protein 
was Duritied essentially according to the methods as described 116.171. 
An i&racellular form-of PLA, 4th an apparent size of 100 kba’w& 
purified to near homogeneity from porcine spleen essentially according 
to the methods described in 1181. 
2.3. Standard assay for PLA, inhibition 
A stock solution of the substrate was prepared as follows: 10-20 
nmol of labeled phospholipid was dried under nitrogen, then suspended 
in 0.5-1.0 ml of distilled water by sonic&ion at 25°C in a bath-type 
son&&or (Ultrasonik 300, NEY). Sonication was performed for 10 s, 
three times. 
The standard incubation system (200~1) for assay of PLAZ contained 
0.33 mnol (1.65 FM) of radioactive substrate (approximately 39,000 
cpm), 10 ng of purified porcine spleen PLAZ, and 200 pug of fatty 
acid-free bovine serum albumin in 75 mM Tris-HCl @H, 7.4). The 
reaction was started by the addition of the enzyme to the reaction 
mixture to give a final volume of 200 ~1. Assays were then incubated 
at 37°C for 1 h (or as indicated), then stopped by the addition of I .25 
ml of Dole’s reagent (2% N-&SO,, 20% n-heptane, 78% ~opro~nol) 
[19]. The hydrolyzed radioactive free fatty acid was extracted and meas- 
ured by liquid scintillation counting according to the methods described 
in [20]. For experiments in which the substrate concentration depend- 
ence was determined, unlabeled phospholipid was added to labeled 
phospholipid to give a designateh final co&mtration. For accurate 
control of Ca*’ concentration. a CaCWEGTA buffering system was 
used [21]. The final calcium co~~n~ti~n was veri&d by-us&g Fura- 
124. In all analyses, samples were tested in more than duplicates and 
adjusted for nonspecific release by subtracting acontrol value in which 
preparation the enzyme was omitted. For inhibition assays, 5-100 ng 
of annexin- was added to the reaction mixture. 
2.4. Zmmunoprecipitation studies 
1 ,ug of the lob kDa porcine spleen PLA, was incubated with or 
without 100 pg of annexin- in 200 ~1 of buffer cont~n~g 75 mM 
Tris-HCl (PH, 7.4), 1 mg&nl bovine serum albumin, and 0.1 PM 
Ca”. After 10 min incubation at 4”C, samples were incubated with anti- 
annexin- polyclonal antibody, then immunocomplexes were precipi- 
tated with Protein-A as described [23]. PLA, activity remaining in the 
supernatant was determined in standard buffer containing 5 mM 
CaCI,. 
3. Results 
3.1 Effect of calcium on the activity of PLA, from 
porcine spleen 
Characteristic features of PLA, from porcine spleen 
used in this study, such as pH dependence, calcium de- 
pendence, and substrate specificity, were similar to those 
of bovine platelet cytosolic enzyme (data not shown) 
[20]. Fig. 1 shows the effect of calcium on enzymatic 
activity. The PLA, was sensitive to free calcium ion 
change especially from 0.1 ,uM to 1 PM with nearly full 
activity at l-5 FM. When compared to 2-AA-PE as a 
substrate, the 2-AA-PC hydrolyzing activity was less 
under all calcium concentrations. 
3.2. Calcium dependence of the PLA, inhibition by 
annexin-l 
In order to investigate the mechanism of PLA, inhibi- 
tion by annexin-I in detail, assays were carried out under 
various concentrations of annexin- and calcium ion. 
Inhibition of PLA, by annexin- was determined using 
2-AA-PE as a substrate at 0.1, 1, 10, 100 ,uM and 1 mM 
calcium ion concentrations. The substrate con~ntration 
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Fig. 1. Calcium dependence of phospholip~e AX activity. 10 ng (0.5 
nM) of purified phospholipase A, (PLAJ from porcine spleen was 
incubated with 0.33 nmole (1.65 ,uM) of 1 -stearoyl-2-[ 1-‘4C]-sn-glycero- 
3-phosphocholine (2-AA-PC) and I-acyl-2-[1 -“‘C]arachidonoyl-s- 
glycero-3-phospho-ethanolamine (2-AA-PE) (approximately 39,000 
cpm) in 75 mM Tris/HCl f&H 7.4) in the presence of various concentra- 
tions of free Ca” for 1 hr at 37°C in a volume of 200 ~1. A, 2-AA-PC, 
u, 2-AA-PE. 
was 1.65 PM, which was a large excess over the enzyme 
(10 q/200 ,& or 0.5 nM) and inhibitor (between 5 r&200 
pl(O.7 nM) and 100 n~2~ #(14 nM)) con~ntrations. 
Fig. 2A shows the percent remaining 2-AA-PE hydrolyz- 
ing activity of PLA, in the presence of 0.7-14 nM an- 
nexin-I. The PLAZ activity decreased in the presence of 
annexin-1, suggesting that enzymatic activity was inhib- 
ited. Inhibition of PLAZ was observed at 0.7 nM an- 
nexin-I which was slightly higher than the enzyme con- 
centration (0.5 nM). Inhibition increased as inhibitor 
concentration increased. Percent remaining activity was 
smallest, and therefore, percent inhibition was largest at 
0.1 PM Ca2+ concentration. It decreased with increasing 
Ca” concentration, and became negligible at 1 mM Ca2” 
concentration. 
Fig. 2B shows a replotting of data in Fig. 2A. The 
percentage of remaining PLA2 activity in the presence of 
annexin- was plotted against the logarithmic value of 
the calcium concentration. At each annexin- concentra- 
tion the plot was essentially linear. 
Experiments to determine the PLA, inhibition by an- 
nexin-I were carried out using 2-AA-PC as a substrate 
in the same manner as experiments with 2-AA-PE. As 
shown in Fig. 2C and D, similar PLA, inhibitory activity 
was observed under 1, 10 and 100 PM Ca” concentra- 
tions. At 0.1 ,uM [Ca’l’], the 2-AA-PC hydrolyz~g activ- 
ity of PLA, was very small (Fig. 1) and the inhibitory 
activity was not measurable. Nevertheless, patterns of 
inhibition were similar between assays with 2-AA-PE 
and 2-AA-PC as substrates. 
In summary, Fig. 2 demonstrates that annexin- inhib- 
its PLAz in the presence of an excess amount of either 
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Fig. 2. Glcimn ~~~n~~on dependence of the phospbo~~e AZ i~~bi~o~ by annexin-I. The inhibi~on of FZA, by annexin- was determkd 
using 2-AA-PE (A,E) and Z-AA-PC (C,D) as a substrate at 0.1, 1, 10, IO0 @I and 1 mM Cs12” concentrations. The reaction was carried out in 75 
mM Tris-HCl @H, 7.4) containing 1 mglml bovine serum albumin for 1 h at 37°C. Concentrations of PLAz and substrate were 0.5 nM (10 ngtZoO 
~1) and I.65 PM, respectively. The annexin- concentration was varied from 0.7 nM (5 ng/200 ~1) to 14 nM (100 ng/200 ~1). PLA, activity with or 
without the inhibitor was determined and percentage of remaining activity in the presence of the inhibitor was calculated. Symbols (A,C): A, 0.1 PM: 
0, 1 @I; +, 10 PM, o, 100 PM; A* 1 mM in Ca2* concentration; @,D) A, 1.4 nM, U, 7.0 nM; o, 14 nM in annexin- concentration. 
Z&AA-PE or &AA-PC as substrate, even though the [I]/ 
[E] value may be as low as 1.4,and the [S]/[I] value as high 
as 2300. Percent inhibition was calcium ion-dependent 
and plots of percent inhibition against log[Ca”] were 
linear. 
Since the substrate con~tration was in large excess 
over the inhibitor, the inhibition of PLAz observed in this 
experiment is not likely due to ‘substrate depletion’ by 
the inhibitor. Instead, the inhibition may be through a 
‘specific interaction’ between annexin- and PLA,. This 
result is consistent with the following interpretation. 
Binding of the substrate to annexin- is calcium ion- 
dependent. At 0.1 PM [Ca”‘j, substrate binding by an- 
nexin-I is minimal, and therefore, annexin- is available 
for PLAz inhibition by direct interaction. Substrate bind- 
ing by annexin- increases with increasing Ca” concen- 
tration, which results in the reduction of free annexin- 
for PLA2 inhibition. At 1 mM fCa2’], annex&I is de- 
pleted by binding to the substrate and is unavailable for 
PLAz inhibition. This interpretation is also consistent 
with the previous studies which were carried out at 1 mM 
calcium where no PLAz inhibition by annexin- was ob- 
served in the presence of a large excess of substrate fg, lOI_ 
3.3, Substrate concentration dependme of the PLA, 
inhibition by annexid 
To eliminate the possibility that the PLA2 inhibition 
by annexin- is due to the substrate depletion, the sub- 
strate concentration was varied from 1.65 yM to 38.3 
FM while holding other components constant. As shown 
in Fig. 3, inhibition of PLA2 by annex&I was essentially 
independent of substrate concentration. This result is in 
sharp contrast to the results from previous studies in 
which PLA, inhibition by annexin- at a limiting sub- 
strate con~ntration was abolished with increasing 
amount of substrate [8,10]. 
Table 1 
Comparison of PLA, activity in supernatants after immunoprecipita- 
tion 
PLAz + antibodyb 1.087 k 0.11 
PLA2 + Annexin I + antibod$ 0.185 + 0.07 
‘PLA, activity remaining in the supernatant after i~~opr~ipitatio~ 
with anti-annexin- antibody. 
b Anti-annexin-I polyclomil antibody. 
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2-AA-PC (PM) 
Fig. 3. Substrate concentration dependence of the PLA, inhibition by 
annexin-I. The reaction was performed as in Fig. 2 except hat the Ca*’ 
and annexin- concentrations were kept constant at 1 PM and 7 nM, 
respectively, and the substrate (2-AA-PC) concentration was varied 
from 1.65 PM to 38.3 PM. 
3.4. Immunoprecipitation studies 
To demonstrate the direct interaction between PLA, 
and annexin-1, co-precipitability of PLA,*annexin-I 
complex, if stably exist in solution, by anti-annexin- 
antibody was investigated. As shown in Table 1, the 
PLA2 activity in the supematant decreased after im- 
munoprecipitation with anti-annexin- antibody when 
annexin- was co-present. Therefore, the presence of 
PLA,*annexin-I complex which was co-precipitated by 
anti-annexin- antibody was demonstrated. 
4. Discussion 
To investigate the mechanism of PLA, inhibition in 
detail, especially to learn whether the inhibition is 
through ‘specific interaction’ or by ‘substrate depletion’, 
we carried out an array of assays under various sub- 
strate, calcium ion, and inhibitor concentrations. Prior 
studies have indicated that PLA,s from several sources 
were not inhibited by annexins in the presence of an 
excess amount of substrate. That is, PLA, inhibition by 
annexins at a limiting substrate concentration was abol- 
ished with increasing substrate concentration [8,10]. In 
contrast, the results of this study showed that inhibition 
of a 100 kDa PLA, from porcine spleen by annexin- was 
independent of substrate concentration. 
The major differences in the assay conditions between 
previous studies and this study are (1) 100 kDa cytosolic 
enzyme from porcine spleen was used in this study 
whereas PLA,s from porcine pancreas (14 kDa), snake 
venom (14 kDa), and a mouse macrophage-like cell line 
(18 kDa) were used in previous studies; (2) the Ca’* 
concentration was between 0.1 PM and 1 mM in this 
study while in all previous studies assays were performed 
at 1 mM [Ca”]; (3) the concentrations of the enzyme, 
substrate, and inhibitor were different. The assay condi- 
tions are summarized in Table 2. The range of [S]/[I] 
values in this study was 120 to 55,000, as compared with 
2.5 to 100 or 36 to 360 in previous studies [&lo]. PLA2 
inhibition was observed at an [Sy[I] value as high as 
55,000 in this study whereas the inhibition was abolished 
at an [S]/[I] value of 50, or negligible at an [S]/[I] value 
of 360, in previous studies [8,10]. It is, therefore, evident 
that PLA, inhibition in this study is not due to substrate 
depletion. The range of [Iy[E] values in this study were 
1.4-28 as compared with 196 in the previous study [8], 
which further supports the specific interaction model. In 
conclusion, the data presented in Table 2 clearly demon- 
strates that PLAz inhibition was observed in this study 
even though the m/[E] value was lower and the [S]/[I] 
value was much higher than in previous studies. 
The discrepancy in results between this and previous 
studies is most likely due to differences in assay condi- 
tions, especially the Ca” concentration. As shown in 
Fig. 2, inhibition of the 100 kDa PLAz by annexin- was 
very sensitive to the Ca*’ concentration, and inhibition 
was negligible at 1 mM [Ca2’]. Therefore, at 1 mM 
[Ca”], PLA2 inhibition by ‘specific interaction’ is small, 
and ‘substrate depletion’ may be a major inhibition 
mechanism. Experiments designed analogously to previ- 
ous studies resulted in data similar to that previously 
observed and interpreted as ‘substrate depletion’ (data 
not shown) [8,10]. At 1 mM [Ca2’], the 100 kDa PLA, 
also follows the substrate depletion mechanism similar 
to the 14 kDa PLA, (data not shown). 
Both 100 kDa and 14 kDa PLA2, which exist in many 
cell types, are thought to be differently regulated [24]. 
Table 2 
Comparison of assay conditions from previous studies and this study 
Component This study Prior study” Prior studyb 
Enzyme 
[El 
Porcine spleen Porcine pancreatic Macrophage-like 
100 kDa PLA, 14 kDa PLA, cell 
0.5 nM 0.51 nM N/A 
Substrate 2-AA-PC E. coli membrane 2-AA-PC 
VI 1.65-38.3 PM 0.25-10 ,uM 10pM 
Inhibitor 
111 
[Ca*+] 
[WI 
Annexin- Annexin- Annexin- 
0.7-14 nM 0.1 nM 2&280 nM 
0.1 ,uM-1 mM 1mM 1 mM 
1.4-28 196 N/A 
lWlI1 120-55,000 2.5-100 36360 
Wl~lmaxd 55,000 50 360 
“Deduced from reference 8. 
bDeduced from reference 10. 
‘Substrate concentration was calculated as a phospholipid monomer 
concentration without considering the actual status of the liposome. 
d Maximum substrate concentration at which PLA, inhibition was ob- 
served. 
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Since the calcium con~ntrations required for activation 
are different between 100 kDa and 14 kDa enzymes, it 
is reasonable to assume that they work by different 
mechanisms in vivo. 
In conclusion, annexin- inhibited a 100 kDa PLA, 
from porcine spleen by a mechanism which is consistent 
with a ‘specific interaction’ model. The Ca” concentra- 
tion was a key factor in determining whether the mecha- 
nism of PLA, inhibition is ‘substrate depletion’ or ‘spe- 
cific interaction’. 
The results presented here are potentially important 
since annexin- SpecifIcally inhibited a 100 kDa PLA, 
near ~~a~ll~ar Ca2+ con~ntration. In view of the se- 
lectivity of the cytosolic PLAz for arachidonate-contain- 
ing phospholipid used in this study, annexin-1 may regu- 
late several biological processes through regulation of 
PLA, activity as has been suggested previously [S-7]. 
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